Author:
Camacho Moll María Elena,Martínez Ana Maria Salinas,Wu Minna,Floriano Gloria Navarrete,Salazar Juan Carlos Romo,Luna Jorge Eleazar Cruz,de León Mario Bermúdez
Reference30 articles.
1. WHO COVID-19 Dashboard. Geneva: World Health Organization, 2020, Available online: https://covid19.who.int/ [Internet]. [cited 2023 Apr 10]. Available from: https://covid19.who.int/info/.
2. Nirmatrelvir-Ritonavir;Lam;React Wkly,1976
3. Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis;Wen;Ann Med,2022
4. Effectiveness of Paxlovid in Reducing Severe Coronavirus Disease 2019 and mortality in high-risk patients;Najjar-Debbiny;Clin Infect Dis,2023
5. Effectiveness of nirmatrelvir/ritonavir (Paxlovid®) in preventing hospitalisation and death among COVID-19 patients: a prospective cohort study;Chew;Med J Malays,2023